Theravance (THRX) Reports Better-Than-Expected Q1 Loss of $0.31

April 22, 2009 4:29 PM EDT

Theravance Inc. (Nasdaq: THRX) reports Q1 loss of $0.31, 1 cent better than the analyst estimate of ($0.32). Revenue for the quarter was $9.5 million, versus the consensus of $7.6 million.


Related Categories

Earnings

Stocks Mentioned

THRX 14.81

+0.15 +1.02%
Volume: 143,061
Track THRX


Add Your Comment